World Covid dispatch: FDA clears third shot for immunocompromised patients

Thailand coronavirus cases hit record high, US FDA amended the emergency use authorizations for both Pfizer-BioNTech and Moderna Covid-19 vaccines

Topics
Coronavirus Vaccine | Coronavirus Tests | Mexico

BS Web Team  |  New Delhi 

Tokyo faces disaster-level crisis on virus

Tokyo Governor Yuriko Koike said the spread of the virus is at disaster levels comparable with the heavy rains and flooding hitting western regions of Japan and urged residents to avoid going out and get vaccinated.

Koike spoke to reporters a day after an expert adviser to the Tokyo government said the virus was out of control. Tokyo reported just under 5,000 new cases Thursday, close to a record marked last week; national case numbers also leaped to a new high of almost 19,000. Read more

FDA clears third shot for certain immunocompromised patients

The U.

S. Food and Drug Administration amended the emergency use authorizations for both the Pfizer-BioNTech and the Moderna COVID-19 vaccines to allow an additional dose for some immunocompromised individuals.

The FDA assessed information on the third dose of Pfizer or Moderna vaccinesm, it said in a statement, adding that other fully vaccinated individuals do not need an additional vaccine dose right now. Read more

Thailand’s new Covid cases hit a record as deaths mount

New infections stood at 23,418 in the past 24 hours with 184 Covid deaths, the government said, taking the total toll to 7,126. Read more

hits record second straight day

posted a record rise in cases Thursday for the second day in a row as the pandemic surges anew in the country.

Cases climbed by 24,975 to 3,045,571, according to Health Ministry data. Deaths rose 608 to 246,811. Read more

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

Read our full coverage on Coronavirus Vaccine
First Published: Fri, August 13 2021. 15:37 IST
RECOMMENDED FOR YOU